AMGN Today - Aug 06: Sales View Boosted
Impossibile aggiungere al carrello
Puoi avere soltanto 50 titoli nel carrello per il checkout.
Riprova più tardi
Riprova più tardi
Rimozione dalla Lista desideri non riuscita.
Riprova più tardi
Non è stato possibile aggiungere il titolo alla Libreria
Per favore riprova
Non è stato possibile seguire il Podcast
Per favore riprova
Esecuzione del comando Non seguire più non riuscita
-
Letto da:
-
Di:
So, here’s the scoop. Amgen kicked off the day strong but ended up slipping a bit. They had some big news about their sales outlook, which initially got folks excited, but it looks like some people decided to cash in those gains by the end of the day.
Now, why the mixed vibes? Amgen just raised their sales forecast by a whopping $1 billion after absolutely crushing expectations in their latest earnings report. That’s some solid news, right? But it seems like investors are also feeling a little cautious. There’s chatter about potential risks looming over the stock, especially with their obesity drug facing some setbacks. So, while the growth is impressive, it’s like people are saying, “Yeah, that’s great, but what’s next?”
Looking ahead, Amgen has a lot of eyes on them with their ongoing innovations. They’re trying to push through some new drugs that could really shake things up in the market. That’s definitely something to keep an ear out for!
So, there you have it! Amgen had a bit of a rollercoaster day, but they’ve got some exciting stuff in the pipeline. Remember, I’m just here sharing info and having fun with this stock stuff, not giving financial advice. Catch you later!
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione